CASI Pharmaceuticals (CASIF) Current Leases (2021 - 2024)
CASI Pharmaceuticals' (CASIF) quarterly Current Leases came in at $1.2 million in Q4 2024, up 67.72% YoY from $728000.0 in Q1 2024, and up 67.72% on a QoQ basis from $728000.0 in Q4 2023.
CASI Pharmaceuticals (CASIF) Current Leases (2021 - 2024) Analysis & Trends
CASI Pharmaceuticals (CASIF) has 4 years of Current Leases data on file, last reported at $1.2 million in Q4 2024.
- Quarterly Current Leases rose 67.72% year-over-year to $1.2 million in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $1.2 million (up 67.72% YoY) and the FY2024 annual result came in at $1.2 million, up 67.72% from the prior year.
- Current Leases rose to $1.2 million in Q4 2024, from $728000.0 in the prior quarter.
- In the past five years, Current Leases ranged from a high of $1.2 million in Q4 2024 to a low of $728000.0 in Q4 2023.
- A 4-year average of $969500.0 and a median of $964500.0 in 2021 frame the typical range for Current Leases.
- Annual changes were most pronounced in 2022 — Current Leases retreated 18.19% — and 2024, when it jumped 67.72%.
- Tracing CASIF's Current Leases over 4 years: stood at $1.1 million in 2021, then dropped by 18.19% to $868000.0 in 2022, then dropped by 16.13% to $728000.0 in 2023, then jumped by 67.72% to $1.2 million in 2024.
- The last three Current Leases figures came in at $1.2 million (Q4 2024), $728000.0 (Q4 2023), and $868000.0 (Q4 2022), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 21.95 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 45.93 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 6.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | CASI Pharmaceuticals | 2.65 Mn | -3.76 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 1.22 Mn |
| Dec 31, 2023 | 728,000.00 |
| Dec 31, 2022 | 868,000.00 |
| Dec 31, 2021 | 1.06 Mn |